The Globe and Mail18h
This Micro Cap Is Getting Bid Up Prior To Opening Bell
A New Jersey-based biotech company is finding quite a bit of success so far during Tuesday’s premarket hours after the ...
Monthly Prescribing Reference19h
FDA to Review Sublingual Cyclobenzaprine for Fibromyalgia Management
The Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for TNX-102 SL (cyclobenzaprine HCL sublingual tablets) for the management of fibromyalgia.
What's Going On With Tonix Pharmaceuticals Stock Today?
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) shares are trading lower Tuesday after initially jumping after the company ...
Crude Oil Down Over 1%; US Industrial Production Declines In November
U.S. industrial production declined by 0.1% from the previous month in November compared to a 0.4% drop in October, and versus market estimates of a 0.2% gain. Commodities In commodity news, oil ...
FDA accepts Tonix’s NDA for non-opioid fibromyalgia drug TNX-102 SL
FDA accepts Tonix’s NDA for TNX-102 SL, a non-opioid fibromyalgia treatment. Learn how this potential new drug addresses ...
Tonix Pharmaceuticals Gets FDA Review of Fibromyalgia Drug
Tonix Pharmaceuticals Holding said the Food and Drug Administration has accepted its application seeking approval of its TNX-102 SL product candidate for the chronic pain condition fibromyalgia.